interferon beta-1a
interferon beta-1a is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including REBIF, Rebif, AVONEX. Available dosage forms: liquid, injection, solution, kit.
Drug details
- Generic Name
- interferon beta-1a
- Brand Names
- REBIF, Rebif, AVONEX
- Application Number
- BLA103780
- Sponsor
- Biogen Inc.
- NDC Codes
- 6
- Dosage Forms
- LIQUID, INJECTION, SOLUTION, KIT
- Routes
- SUBCUTANEOUS, INTRAMUSCULAR
- Active Ingredients
- INTERFERON BETA-1A
Indications and Usage
1 INDICATIONS AND USAGE AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. AVONEX is for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )